PROPOFOL injection, emulsion

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

propofol (UNII: YI7VU623SF) (propofol - UNII:YI7VU623SF)

Available from:

Sagent Pharmaceuticals

Administration route:

INTRAVENOUS

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Propofol Injectable Emulsion is an intravenous general anesthetic and sedation drug indicated for: - Induction of General Anesthesia for Patients Greater than or Equal to 3 Years of Age - Maintenance of General Anesthesia for Patients Greater than or Equal to 2 Months of Age - Initiation and Maintenance of Monitored Anesthesia Care (MAC) Sedation in Adult Patients - Sedation for Adult Patients in Combination with Regional Anesthesia - Intensive Care Unit (ICU) Sedation of Intubated, Mechanically Ventilated Adult Patients Limitations of Use Propofol Injectable Emulsion is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations [see Pediatric Use (8.4)] . Safety, effectiveness and dosing guidelines for Propofol Injectable Emulsion have not been established for MAC sedation in the pediatric population; therefore, it is not recommended for this use [see Pediat

Product summary:

Propofol Injectable Emulsion, USP is available as follows: Contains a sulfite. Storage Conditions Store between 4° to 25°C (40° to 77°F). Do not freeze. Shake well before use. Discard unused portion. Sterile, Nonpyrogenic. The container closure is not made with natural rubber latex.

Authorization status:

Abbreviated New Drug Application

Summary of Product characteristics

PROPOFOL- PROPOFOL INJECTION, EMULSION
SAGENT PHARMACEUTICALS
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
PROPOFOL INJECTABLE
EMULSION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR
PROPOFOL
INJECTABLE EMULSION.
PROPOFOL INJECTABLE EMULSION, FOR INTRAVENOUS USE
INITIAL U.S. APPROVAL: 1991
INDICATIONS AND USAGE
Propofol Injectable Emulsion is an intravenous general anesthetic and
sedation drug indicated for:
Induction of General Anesthesia for Patients Greater than or Equal to
3 Years of Age (1)
Maintenance of General Anesthesia for Patients Greater than or
Equal to 2 Months of Age (1)
Initiation and Maintenance of Monitored Anesthesia Care (MAC) Sedation
in Adult Patients (1)
Sedation for Adult Patients in Combination with Regional Anesthesia
(1)
Intensive Care Unit (ICU) Sedation of Intubated, Mechanically
Ventilated Adult Patients (1)
Limitations of Use
Propofol Injectable Emulsion is not recommended for induction of
anesthesia below the age of 3 years or
for maintenance of anesthesia below the age of 2 months (1)
MAC sedation in the pediatric population is not recommended (1)
Propofol Injectable Emulsion is not indicated for use in Pediatric ICU
sedation (1)
DOSAGE AND ADMINISTRATION
See Full Prescribing Information for detailed dosing instructions (2)
DOSAGE FORMS AND STRENGTHS
Injectable emulsion: 200 mg per 20 mL (10 mg per mL), 500 mg per 50 mL
(10 mg per mL), and 1,000 mg
per 100 mL (10 mg per mL) single-dose vials (3)
CONTRAINDICATIONS
Known hypersensitivity to propofol, egg or soybean (4)
WARNINGS AND PRECAUTIONS
Hypersensitivity Reactions: Serious and sometimes fatal reactions
(5.1)
Microbial Contamination: Strict aseptic technique must be maintained
during handling. Propofol injectable
emulsion vials are never to be accessed more than once or used on more
than one person.
Administration should commence promptly and be completed within 12
hours after the vial has been
opened. Discard unused drug product. Do not use if